ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety
Author(s) -
Alison B. Kohan,
Fei Wang,
Chunmin C. Lo,
Min Liu,
Patrick Tso
Publication year - 2015
Publication title -
ajp gastrointestinal and liver physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.644
H-Index - 169
eISSN - 1522-1547
pISSN - 0193-1857
DOI - 10.1152/ajpgi.00098.2014
Subject(s) - chylomicron , glucose homeostasis , lipid metabolism , endocrinology , homeostasis , medicine , energy homeostasis , small intestine , biology , carbohydrate metabolism , cholesterol , diabetes mellitus , chemistry , lipoprotein , insulin resistance , obesity , very low density lipoprotein
Apolipoprotein A-IV (apoA-IV) is secreted by the small intestine on chylomicrons into intestinal lymph in response to fat absorption. Many physiological functions have been ascribed to apoA-IV, including a role in chylomicron assembly and lipid metabolism, a mediator of reverse-cholesterol transport, an acute satiety factor, a regulator of gastric function, and, finally, a modulator of blood glucose homeostasis. The purpose of this review is to update our current view of intestinal apoA-IV synthesis and secretion and the physiological roles of apoA-IV in lipid metabolism and energy homeostasis, and to underscore the potential for intestinal apoA-IV to serve as a therapeutic target for the treatment of diabetes and obesity-related disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom